Harvard Bioscience (HBIO) Cash from Investing Activities Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -110.20% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 19.67% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -44.16% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -186.92% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -222.38% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 42.55% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 20.91% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -13.64% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -1.74% |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | -293.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -293.13% |
| Mar 31, 2026 | 9.22% |
| Dec 31, 2025 | -28.54% |
| Sep 30, 2025 | 68.68% |
| Jun 30, 2025 | -150.87% |
| Mar 31, 2025 | -203.56% |
| Dec 31, 2024 | 56.08% |
| Sep 30, 2024 | -177.06% |
| Jun 30, 2024 | 173.28% |
| Mar 31, 2024 | -178.13% |
| Dec 31, 2023 | -351.49% |
| Sep 30, 2023 | 9.28% |
| Jun 30, 2023 | -41.40% |
| Mar 31, 2023 | 161.15% |
| Dec 31, 2022 | 34.36% |
| Sep 30, 2022 | 7.92% |
| Jun 30, 2022 | -114.56% |
| Mar 31, 2022 | -56.48% |
| Dec 31, 2021 | -14.01% |
| Sep 30, 2021 | 14.89% |